The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study
Open accessAbstract
BACKGROUND: Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive decline in women over age 65 y. It is unknown whether similar risks exist for recently postmenopausal women, and whether MHT affects mood in younger women. The ancillary Cognitive and Affective Study (KEEPS-Cog) of the Kronos Early Estrogen Prevention Study (KEEPS) examined the effects of up to 4 y of MHT on cognition and mood in recently postmenopausal women. METHODS AND FINDINGS: KEEPS, a randomized, double-blinded, placebo-controlled clinical trial, was conducted at nine US academic centers. Of the 727 women enrolled in KEEPS, 693 (95.3%) participated in the ancillary KEEPS-Cog, with 220 women randomized to receive 4 y of 0.45 mg/d oral conjugated equine estrogens (o-CEE) plus 200 mg/d micronized progesterone (m-P) for the first 12 d of each month, 211 women randomized to receive 50 μg/d transdermal estradiol (t-E2) plus 200 mg/d m-P for the first 12 d of each month, and 262 women randomized to receive placebo pills and patches. Primary outcomes included the Modified Mini-Mental State examination; four cognitive factors: verbal learning/memory, auditory attention/working memory, visual attention/executive function, and speeded language/mental flexibility; and a mood measure, the Profile of Mood States (POMS). MHT effects were analyzed using linear mixed-effects (LME) models, which make full use of all available data from each participant, including those with missing data. Data from those with and without full data were compared to assess for potential biases resulting from missing observations. For statistically significant results, we calculated effect sizes (ESs) to evaluate the magnitude of changes. On average, participants were 52.6 y old, and 1.4 y past their last menstrual period. By month 48, 169 (24.4%) and 158 (22.8%) of the 693 women who consented for ancillary KEEPS-Cog were lost to follow-up for cognitive assessment (3MS and cognitive factors) and mood evaluations (POMS), respectively. However, because LME models make full use all available data, including data from women with missing data, 95.5% of participants were included in the final analysis (n = 662 in cognitive analyses, and n = 661 in mood analyses). To be included in analyses, women must have provided baseline data, and data from at least one post-baseline visit. The mean length of follow-up was 2.85 y (standard deviation [SD] = 0.49) for cognitive outcomes and 2.76 (SD = 0.57) for mood outcomes. No treatment-related benefits were found on cognitive outcomes. For mood, model estimates indicated that women treated with o-CEE showed improvements in depression and anxiety symptoms over the 48 mo of treatment, compared to women on placebo. The model estimate for the depression subscale was -5.36 × 10(-2) (95% CI, -8.27 × 10(-2) to -2.44 × 10(-2); ES = 0.49, p < 0.001) and for the anxiety subscale was -3.01 × 10(-2) (95% CI, -5.09 × 10(-2) to -9.34 × 10(-3); ES = 0.26, p < 0.001). Mood outcomes for women randomized to t-E2 were similar to those for women on placebo. Importantly, the KEEPS-Cog results cannot be extrapolated to treatment longer than 4 y. CONCLUSIONS: The KEEPS-Cog findings suggest that for recently postmenopausal women, MHT did not alter cognition as hypothesized. However, beneficial mood effects with small to medium ESs were noted with 4 y of o-CEE, but not with 4 y of t-E2. The generalizability of these findings is limited to recently postmenopausal women with low cardiovascular risk profiles. TRIAL REGISTRATION: ClinicalTrials.gov NCT00154180 and NCT00623311.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Wechsler Adult Intelligence Scale-III
Ryan, J. J., & Lopez, S. J. (2001) · Understanding Psychological Assessment · doi:10.1007/978-1-4615-1185-4_2 · Cited by 3,731
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471 · cited 1×
“Standards for interpreting the clinical significance of POMS score changes were established for clinical trials examining pain control [46].”
Method(1987) · PubMed · Cited by 2,657
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“Consistent with published literature [45], the most common APOE allele was ε3 among 568 women genotyped, representing 78.”
ResultStroop Color and Word Test: Manual for Clinical and Experimental Uses.
Golden, C. J., Golden, C. J., & Golden, C. (1978) · NSUWorks (Nova Southeastern University) · Cited by 1,814
California Verbal Learning Test
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (2016) · PsycTESTS Dataset · doi:10.1037/t48844-000 · Cited by 1,319
Contributions to Neuropsychological Assessment
Sarazin, F. (1996) · Europe PMC (PubMed Central) · Cited by 1,151
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., & Metter, E. (1997) · Neurology · doi:10.1212/wnl.48.6.1517 · Cited by 966
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
Self-citationEspeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
Sherwin, B. B. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90060-1 · Cited by 703
de Novaes Soares, C., Almeida, O. P., Joffe, H., & Cohen, L. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.529 · Cited by 691
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Paganini‐Hill, A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.19.2213 · Cited by 524
Bromberger, J. T., Kravitz, H. M., Chang, Y.-F., Cyranowski, J. M., Brown, C., & Matthews, K. A. (2011) · Psychological Medicine · doi:10.1017/s003329171100016x · Cited by 439
KEEPS: The Kronos Early Estrogen Prevention Study
Harman, S., Brinton, E., Cedars, M., Lobo, R., Manson, J., Merriam, G., Miller, V., Naftolin, F., & Santoro, N. (2005) · Climacteric · doi:10.1080/13697130500042417 · Cited by 397
Self-citationA Compendium of Neuropsychological Tests, 2nd ed
(2000) · Archives of Neurology · doi:10.1001/archneur.57.2.278 · Cited by 377
Harman, S. M., Black, D. M., Naftolin, F., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hopkins, P. N., Lobo, R. A., Manson, J. E., Merriam, G. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0353 · Cited by 344
Self-citationBravo, G., & H�bert, R. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199710)12:10<1008::aid-gps676>3.0.co;2-a · Cited by 344
A meta-analysis of the effect of hormone replacement therapy upon depressed mood
Zweifel, J. E., & O'Brien, W. H. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00034-0 · Cited by 330
Bromberger, J. T., Schott, L. L., Kravitz, H. M., Sowers, M., Avis, N. E., Gold, E. B., Randolph, J. F., & Matthews, K. A. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.55 · Cited by 320
Mixed-effects models in psychophysiology
BAGIELLA, E., SLOAN, R. P., & HEITJAN, D. F. (2000) · Psychophysiology · doi:10.1017/s0048577200980648 · Cited by 314
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick, S. M., Maki, P. M., Rapp, S. R., Espeland, M. A., Brunner, R., Coker, L. H., Granek, I. A., Hogan, P., Ockene, J. K., & Shumaker, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2097 · Cited by 310
Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
Resnick, S. M., & Henderson, V. W. (2002) · JAMA · doi:10.1001/jama.288.17.2170 · Cited by 287
Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study
Resnick, S. M., Espeland, M. A., Jaramillo, S. A., Hirsch, C., Stefanick, M. L., Murray, A. M., Ockene, J., & Davatzikos, C. (2009) · Neurology · doi:10.1212/01.wnl.0000339037.76336.cf · Cited by 267
Daniel, J. M., Hulst, J. L., & Berbling, J. L. (2006) · Endocrinology · doi:10.1210/en.2005-0998 · Cited by 262
Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study
Shao, H., Breitner, J. C. S., Whitmer, R. A., Wang, J., Hayden, K., Wengreen, H., Corcoran, C., Tschanz, J., Norton, M., Munger, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f823 · Cited by 260
Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women
Sherwin, B. B. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90061-4 · Cited by 258
Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
Baldereschi, M., Di Carlo, A., Lepore, V., Bracco, L., Maggi, S., Grigoletto, F., Scarlato, G., Amaducci, L., & ILSA Working Group* (1998) · Neurology · doi:10.1212/wnl.50.4.996 · Cited by 257
Joffe, H., Hall, J. E., Gruber, S., Sarmiento, I. A., Cohen, L. S., Yurgelun-Todd, D., & Martin, K. A. (2006) · Menopause · doi:10.1097/01.gme.0000189618.48774.7b · Cited by 238
Role of Estrogen in the Aetiology and Treatment of Mood Disorders
Halbreich, U., & Kahn, L. S. (2001) · CNS Drugs · doi:10.2165/00023210-200115100-00005 · Cited by 229
Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly
Kluger, A., Ferris, S. H., Golomb, J., Mittelman, M. S., & Reisberg, B. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200402 · Cited by 227
Espeland, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7727 · Cited by 226
Espeland, M. A., Rapp, S. R., Shumaker, S. A., Brunner, R., Manson, J. E., Sherwin, B. B., Hsia, J., Margolis, K. L., Hogan, P. E., Wallace, R., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000140471.21348.f1 · Cited by 222
Self-citationGrady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C., & Barrett-Connor, E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01270-6 · Cited by 222
Alteration in the Hypothalamic-Pituitary-Ovarian Axis in Depressed Women
Young, E. A., Midgley, A. R., Carlson, N. E., & Brown, M. B. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1157 · Cited by 187
BRINTON, R. D. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.005 · Cited by 176
Ethnic Differences in Mini‐Mental State Examination (MMSE) Scores: Where You Live Makes a Difference
Espino, D. V., Lichtenstein, M. J., Palmer, R. F., & Hazuda, H. P. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49111.x · Cited by 174
Nilsen, J., Chen, S., Irwin, R. W., Iwamoto, S., & Brinton, R. D. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-74 · Cited by 174
Neurobiological Underpinnings of the Estrogen - Mood Relationship
Wharton, W., E. Gleason, C., Sandra, O., M. Carlsson, C., & Asthana, S. (2012) · Current Psychiatry Reviews · doi:10.2174/157340012800792957 · Cited by 167
Self-citationEarly postmenopausal hormone therapy may prevent cognitive impairment later in life
Bagger, Y. Z., Tank??, L. B., Alexandersen, P., Qin, G., & Christiansen, C. (2005) · Menopause · doi:10.1097/00042192-200512010-00005 · Cited by 165
Estrogen and memory in women: how can we reconcile the findings?
Sherwin, B. B. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.12.002 · Cited by 164
Miller, V. M., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hodis, H. N., Løbo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F. N., et al. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9104-y · Cited by 150
Self-citationChange in psychological and vasomotor symptom reporting during the menopause
Hardy, R., & Kuh, D. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00326-4 · Cited by 142
Bhavnani, B. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00220-6 · Cited by 127
Mitochondria Play a Central Role in Estrogen-Induced Neuroprotection
Simpkins, J. W., Wang, J., Wang, X., Perez, E., Prókai, L., & Dykens, J. A. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053005073 · Cited by 124
Depression and anxiety through the climacteric period: An epidemiological study (HUNT-II)
Tangen, T., & Mykletun, A. (2008) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/01674820701733945 · Cited by 118
Hogervorst, E., & Bandelow, S. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.02.005 · Cited by 109
Resnick, S. M., Espeland, M. A., An, Y., Maki, P. M., Coker, L. H., Jackson, R. D., Stefanick, M. L., Wallace, R. B., Rapp, S. R., & for the Women’s Health Initiative Study of Cognitive Aging Investigators (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1340 · Cited by 108
Zhao, L., & Brinton, R. D. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-24 · Cited by 98
Braden, B. B., Talboom, J. S., Crain, I. D., Simard, A. R., Lukas, R. J., Prókai, L., Scheldrup, M. R., Bowman, B. L., & Bimonte‐Nelson, H. A. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.01.002 · Cited by 90
Progesterone-Induced Neuroprotection
Singh, M. (2006) · Endocrine · doi:10.1385/endo:29:2:271 · Cited by 76
Wharton, W., Gleason, C. E., Miller, V. M., & Asthana, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.011 · Cited by 74
Self-citationBraden, B. B., Garcia, A. N., Mennenga, S. E., Prókai, L., Villa, S. R., Acosta, J. I., Lefort, N., Simard, A. R., & Bimonte‐Nelson, H. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2322-4 · Cited by 61
Uterine and Vaginal Effects of Unopposed Ultralow-Dose Transdermal Estradiol
Johnson, S. R., Ettinger, B. B., Macer, J. L., Ensrud, K. E., Quan, J., & Grady, D. G. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000157116.23249.52 · Cited by 59
Woods, N. F., Mariella, A., & Mitchell, E. S. (2002) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810708.x · Cited by 56
Sherwin, B. B., & Grigorova, M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.079 · Cited by 54
Dowling, N. M., Gleason, C. E., Manson, J. E., Hodis, H. N., Miller, V. M., Brinton, E. A., Neal-Perry, G. S., Santoro, M. N., Cedars, M. I., Løbo, R. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068741 · Cited by 54
Self-citationCasanova, G. K., Ramos, R. B., Ziegelmann, P. K., & Spritzer, P. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3301 · Cited by 52
Brain Volumes, Cognitive Impairment, and Conjugated Equine Estrogens
Espeland, M. A., Tindle, H. A., Bushnell, C. A., Jaramillo, S. A., Kuller, L. H., Margolis, K. L., Mysiw, W. J., Maldjian, J. A., Melhem, E. R., Resnick, S. M., et al. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp128 · Cited by 51
Yun, Y. U. E., Hu, L., Qin-jie, T. I. A. N., JIANG, J.-M., Yi-long, D. O. N. G., Jin, Z., CHENG, Y.-H., Hong, X., Ge, Q.-S., & Ping-ping, Z. U. O. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00618.x · Cited by 49
Paoletti, A. M., Floris, S., Mannias, M., Orrù, M., Crippa, D., Orlandi, R., Zompo, M. D., & Melis, G. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7179 · Cited by 45
Progesterone-induced neuroprotection: Factors that may predict therapeutic efficacy
Singh, M., & Su, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.027 · Cited by 44
Validation of POMS questionnaire in postmenopausal women
Wyrwich, K. W., & Yu, H. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9846-2 · Cited by 44
Hawkins, K. A., Cromer, J. R., Piotrowski, A. S., & Pearlson, G. D. (2011) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acr054 · Cited by 22
Casanova, G. K., dos Reis, A. M., & Spritzer, P. M. (2014) · Climacteric · doi:10.3109/13697137.2014.940309 · Cited by 21
Talboom, J. S., Engler-Chiurazzi, E. B., Whiteaker, P., Simard, A. R., Lukas, R. J., Acosta, J. I., Prókai, L., & Bimonte‐Nelson, H. A. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.09.002 · Cited by 20
Brain health and cognitive and mood disorders in ageing women
Silva, I., & Naftolin, F. N. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.06.005 · Cited by 14
Self-citationSamsioe, G., & Hruska, J. (2009) · Climacteric · doi:10.3109/13697130903480706 · Cited by 12
Reproductive hormonal treatments for mood disorders in women
Schmidt, P. J., & Rubinow, D. R. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.2/pschmidt · Cited by 9
Cited by
Sex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Self-citation2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Understanding the impact of sex and gender in Alzheimer’s disease: A call to action
Nebel, R. A., Aggarwal, N. T., Barnes, L. L., Gallagher, A., Goldstein, J. M., Kantarci, K., Mallampalli, M. P., Mormino, E. C., Scott, L., Yu, W. H., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.04.008 · Cited by 839
“[80] Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, et al.”
Metadata
- Authors
- Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., Neal-Perry, G., Santoro, N. F., Taylor, H. S., Black, D. M., Budoff, M. J., Hodis, H. N., Naftolin, F., Harman, S. M., & Asthana, S.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-02
- Volume
- 12
- Issue
- 6
- Pages
- e1001833
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W578040726
- Cited by
- 490
- References
- 74
- FWCI
- 38.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.